GENTHERM Inc
For the period ended Jun 30, 2024. Filed Jul 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 31, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-03-31; filed 2024-04-30.
0000950170-24-050570
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsCurrent report: 10-Q
Period ended 2024-06-30; filed 2024-07-31.
0000950170-24-088484
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 5 previous paragraphs and 6 current paragraphs.
3 unchanged; 2 reworded; 1 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Reworded paragraphs (2)
Previous wording
Issuer Purchases of Equity Securities During First Quarter 2024
Current wording
Issuer Purchases of Equity Securities During Second Quarter 2024
Previous wording
For further information regarding the ASR Agreement and the final settlement date that is scheduled to occur in the second quarter of 2024, see Note 12, "Equity," to the notes to the consolidated condensed financial statements included in this Report.
Current wording
With the expiration of the 2020 Stock Repurchase Program on June 30, 2024 followed immediately by the commencement of the 2024 Stock Repurchase Program, the Company is authorized to repurchase up to $150 million of its issued and outstanding Common Stock as of June 30, 2024. The 2020 Stock Repurchase Program had $17.5 million of repurchase authorization remaining at the time of expiration. For further information, see Note 12, "Equity," to the notes to the consolidated condensed financial statements included in this Report.